Reckitt Benckiser : Circular re Demerger and Notice of General Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Reckitt Benckiser Group plc (the "Company")

Publication of Circular

17 November 2014

Further to the announcement made earlier today by the Company regarding the proposed demerger of the Company's pharmaceutical business (the "Demerger"), the Company announces that a circular outlining the details of the Demerger and the resolution to be considered at the Company's general meeting to be held on 11 December 2014, together with notice of that meeting (the "Circular") is being posted or otherwise made available to the Company's shareholders today.  The Circular has been approved by the UK Listing Authority.  A copy of the Circular is available on the Company's website: http://www.rb.com.

A copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for viewing at: http://www.morningstar.co.uk/uk/nsm

For further information please contact:

 William R Mordan
 Company Secretary

Tel: +44 (0)1753 217800

Disclaimer

The Company's ordinary shares have not been and will not be registered under the Securities Act of 1933 and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933.